# Marine Algae: Bioactive Compounds & Pharmaceutical Potential
> Explore the science of marine algae, bioactive molecules like fucoidan, and extraction methods for pharmaceuticals, nutraceuticals, and functional foods.

Tags: marine-algae, bioactive-compounds, biotechnology, pharmaceuticals, nutraceuticals, green-extraction, fucoidan, marine-science
## Marine Algae as a Source of Bioactive Compounds
- Research presentation on the ocean's pharmaceutical potential.
- Key stats: ~30,000 algae species known; >1,000 bioactive compounds identified; $12B+ global seaweed market value.

## Classification of Marine Algae
- **Green Algae (Chlorophyta):** Rich in polysaccharides (Ulvan) and pigments.
- **Brown Algae (Phaeophyta):** Most bioactive, high in Fucoidan, Alginic acid, and Phlorotannins.
- **Red Algae (Rhodophyta):** Source of Carrageenan and Agar.
- **Microalgae:** High in EPA, DHA (omega-3s), and Astaxanthin.

## Key Bioactive Molecules
- **Polysaccharides:** Fucoidan, carrageenan (anti-inflammatory).
- **Polyphenols:** Phlorotannins (antioxidant, antimicrobial).
- **Pigments:** Fucoxanthin, astaxanthin (anticancer properties).
- **Fatty Acids:** EPA, DHA (cardioprotective).
- **Proteins & Peptides:** Phycobiliproteins (ACE-inhibitory activity).

## Pharmacological Activities
- Antioxidant, Antimicrobial, Anti-inflammatory, Anticoagulant, Anticancer, and Antiviral properties.
- Specific compounds like Fucoidan induce apoptosis in cancer cell lines.

## Extraction Methods
- **Microwave-Assisted Extraction (MAE):** Highest efficiency, ~70 mg/g yield.
- **Ultrasound-Assisted Extraction (UAE):** Gentle cell disruption via cavitation.
- **Supercritical Fluid Extraction (SFE):** High purity using CO2 solvent.

## Industry Applications
- **Pharma:** Anti-cancer and anti-viral drugs.
- **Nutraceuticals:** Omega-3 supplements and functional fibers.
- **Cosmetics:** Anti-aging and UV protection.
- **Biofuels:** Sustainable energy feedstocks from microalgae.

## Challenges and Timeline
- Obstacles: Industrial scalability, seasonal variability, and regulatory hurdles.
- Milestones: 2024 first algae-based antiviral clinical trials; 2030+ mainstream pharmaceutical integration.
---
This presentation was created with [Bobr AI](https://bobr.ai) — an AI presentation generator.